Clinical Trials Browser

Phase 4 × INDUSTRY × Topotecan × Clear all

NCT05874401 2025-09-04

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Phase 4 Recruiting

Small Cell Lung Carcinoma